HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The authors' reply to Allen et al.: "A Comment on Boyers et al.: 'eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal'".

AuthorsDwayne Boyers, Xueli Jia, David Jenkinson, Graham Mowatt
JournalPharmacoEconomics (Pharmacoeconomics) Vol. 31 Issue 1 Pg. 91 (Jan 2013) ISSN: 1179-2027 [Electronic] New Zealand
PMID23329596 (Publication Type: Comment, Letter)
Chemical References
  • Benzoates
  • Hydrazines
  • Pyrazoles
Topics
  • Benzoates (therapeutic use)
  • Humans
  • Hydrazines (therapeutic use)
  • Purpura, Thrombocytopenic, Idiopathic (drug therapy)
  • Pyrazoles (therapeutic use)
  • Technology Assessment, Biomedical (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: